Legal Opinion

Chiesi USA, Inc. v. Sandoz Inc.

District Court, D. New Jersey

Decided August 21, 2014No. Civil No. 13-5723 (NLH/AMD)PublishedCited by 2 opinions

1Opinion of the Court

MEMORANDUM OPINION AND ORDER

ANN MARIE DONIO, United States Magistrate Judge.

In this patent infringement action, Plaintiffs Chiesi USA, Inc., Cornerstone Biopharma, Inc., and EKR Therapeutics, LLC (collectively, “Plaintiffs”) generally allege that Defendant Sandoz Inc.’s (hereinafter, “Defendant”) attempt to produce, market, and/or distribute a generic ready-to-use premixed nicardipine injection infringes four of Plaintiffs’ patents. Presently before the Court are the parties’ various submissions concerning the entry of a discovery confidentiality order (hereinafter, “DCO”). The parties agree…

2Cases cited4 opinions

  1. In Re Deutsche Bank Trust Co. AmericasCourt of Appeals for the Federal Circuit · 2010
  2. In Re VIOLATION OF RULE 28(D)Court of Appeals for the Federal Circuit · 2011
  3. EON Corp. IP Holdings, LLC v. AT & T Mobility LLCDistrict Court, D. Puerto Rico · 2012
  4. Nexedge, LLC v. Freescale Semiconductor, Inc.District Court, D. Arizona · 2011

3Cited by2 opinions

  1. Front Row Technologies, LLC v. NBA Media Ventures, LLCDistrict Court, D. New Mexico · 2015
  2. Ultra Premium Services, LLC v. OFS International, LLCDistrict Court, S.D. Texas · 2019

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API